<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">2975</id>
  <title>T3D2933</title>
  <common-name>Mesoridazine</common-name>
  <description>Mesoridazine is only found in individuals that have used or taken this drug. It is a phenothiazine antipsychotic with effects similar to chlorpromazine. [PubChem]Based upon animal studies, mesoridazine, as with other phenothiazines, acts indirectly on reticular formation, whereby neuronal activity into reticular formation is reduced without affecting its intrinsic ability to activate the cerebral cortex. In addition, the phenothiazines exhibit at least part of their activities through depression of hypothalamic centers. Neurochemically, the phenothiazines are thought to exert their effects by a central adrenergic blocking action.</description>
  <cas>5588-33-0</cas>
  <pubchem-id>4078</pubchem-id>
  <chemical-formula>C21H26N2OS2</chemical-formula>
  <weight>386.148660</weight>
  <appearance>White powder.</appearance>
  <melting-point></melting-point>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility>7.67e-02 g/L</solubility>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure>Oral; Intramuscular injection. Well absorbed from the gastrointestinal tract.</route-of-exposure>
  <target nil="true"/>
  <mechanism-of-toxicity>Based upon animal studies, mesoridazine, as with other phenothiazines, acts indirectly on reticular formation, whereby neuronal activity into reticular formation is reduced without affecting its intrinsic ability to activate the cerebral cortex. In addition, the phenothiazines exhibit at least part of their activities through depression of hypothalamic centers. Neurochemically, the phenothiazines are thought to exert their effects by a central adrenergic blocking action.</mechanism-of-toxicity>
  <metabolism>Half Life: 24 to 48 hours</metabolism>
  <toxicity>Oral LD&lt;sub&gt;50&lt;/sub&gt; is 560 &amp;plusmn; 62.5 mg/kg and 644 &amp;plusmn; 48 mg/kg in mouse and rat, respectively. </toxicity>
  <lethaldose nil="true"/>
  <carcinogenicity>No indication of carcinogenicity to humans (not listed by IARC).</carcinogenicity>
  <use-source>Used in the treatment of schizophrenia, organic brain disorders, alcoholism and psychoneuroses.</use-source>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms>Symptoms of overdose may include emesis, muscle tremors, decreased food intake and death associated with aspiration of oral-gastric contents into the respiratory system.</symptoms>
  <treatment nil="true"/>
  <created-at type="dateTime">2009-07-21T20:27:59Z</created-at>
  <updated-at type="dateTime">2014-12-24T20:25:53Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia>Mesoridazine</wikipedia>
  <uniprot-id></uniprot-id>
  <kegg-compound-id>C07143</kegg-compound-id>
  <omim-id></omim-id>
  <chebi-id>6780</chebi-id>
  <biocyc-id></biocyc-id>
  <ctd-id nil="true"/>
  <stitch-id>Mesoridazine</stitch-id>
  <drugbank-id>DB00933</drugbank-id>
  <pdb-id></pdb-id>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CN1CCCCC1CCN1C2=CC=CC=C2SC2=C1C=C(C=C2)S(C)=O</moldb-smiles>
  <moldb-formula>C21H26N2OS2</moldb-formula>
  <moldb-inchi>InChI=1/C21H26N2OS2/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(26(2)24)15-19(21)23/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3</moldb-inchi>
  <moldb-inchikey>InChIKey=SLVMESMUVMCQIY-UHFFFAOYNA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">386.574</moldb-average-mass>
  <moldb-mono-mass type="decimal">386.148654844</moldb-mono-mass>
  <origin>Exogenous</origin>
  <state>Solid</state>
  <logp>3.9</logp>
  <hmdb-id>HMDB15068</hmdb-id>
  <chembl-id>CHEMBL1088</chembl-id>
  <chemspider-id>3936</chemspider-id>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference>&lt;p&gt;&lt;a href="http://www.drugsyn.org/Mesoridazine.htm"&gt;DrugSyn.org&lt;/a&gt;&lt;/p&gt;</synthesis-reference>
  <structure-image-caption nil="true"/>
</compound>
